Previous 10 | Next 10 |
Zogenix (NASDAQ: ZGNX) stock is having the ride of its life this week -- perhaps for the last time in its history. The biotech announced Wednesday it agreed to be acquired by Belgium-based pharmaceutical company UCB (OTC: UCBJF) . The deal is valued at up to $1.9 billion whe...
Here Are 5 Biotech Stocks To Check Out In The Stock Market Today As we move into the rest of 2022, it seems that biotech stocks could continue to be a viable play in the stock market. This can be attributed to the ongoing coronavirus concerns fueling the booming industry. Now, a...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Splash Beverage (NYSEAMERICAN: SBEV ) stock is soaring higher on Wednesday after the company revealed a new deal bringing its drinks to additional stores. Source: Abdul Razak Latif / Shutterstock.com This deal...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genius Sports (NYSE: GENI ) stock is on the rise Wednesday after an analyst initiated coverage of the sports data and tech company. Source: Karolis Kavolelis / Shutterstock.com Credit Suisse analyst Benjamin C...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Zogenix (NASDAQ: ZGNX ) stock is skyrocketing on Wednesday following news that UCB (OTCMKTS: UCBJY ) intends to acquire the company in a $1.9 billion deal. Source: Shutterstock.com The deal between the t...
MONSEY, N.Y., Jan. 19, 2022 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Zogenix, Inc. (Nasdaq: ZGNX) (“Zogenix”) acted in the best interests of ZGNX shareholders in approving the proposed acquisition of Zogenix by UCB, ...
Shares of the small-cap drugmaker Zogenix (NASDAQ: ZGNX) rose by as much as 67% in pre-market trading Wednesday morning. The company's shares are surging higher today in response to a buyout agreement with the Belgian pharmaceutical company UCB. UCB will reportedly pay $ 26 ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re diving right into trading today with the biggest pre-market stock movers for Wednesday! Source: Eric Urquhart/Shutterstock.com Moving stocks this morning are clinical trials, ear...
UCB to acquire Zogenix - Transaction broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy, complementing existing medicines and expanding clinical development pipeline of epilepsy and rare dise...
Zogenix (NASDAQ:ZGNX) has submitted a New Drug Application (NDA) to the Japanese Ministry of Health, Labour & Welfare (MHLW) for the marketing approval of Fintepla (fenfluramine) for the treatment of epileptic seizures associated with Dravet syndrome. The submission is supported by the re...
News, Short Squeeze, Breakout and More Instantly...
UCB Completes Acquisition of Zogenix, Inc. - Broadens and builds upon UCB's role as a leader in, and our continued commitment to, addressing unmet needs of people living with epilepsy - Total transaction value of up to approximately US$ 1.9 billion / € 1.7 billion. Th...
Zogenix Inc. (NASDAQ:ZGNX) traded today at a new 52-week high of $26.66. Approximately 1.2 million shares have changed hands today, as compared to an average 30-day volume of 3.7 million shares. Zogenix Inc. (NASDAQ:ZGNX) defies analysts with a current price ($26.57) 0.4% above its avera...
Two podium and one poster presentation share important new findings on FINTEPLA’s safety profile and its impact on non-seizure related benefits for LGS patients LGS is a debilitating childhood-onset developmental and epileptic encephalopathy estimated to affect approx...